ASHLEY MARTIGNONI: Open Payments
NPI 1063129351 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,965 in 68 payments from 11 companies in 2025. Trend: 2023 $1,167 · 2024 $1,494 · 2025 $1,965
Food & beverage: $1,965
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $514 |
| Janssen Biotech, Inc. | 28 | $473 |
| ABBVIE INC. | 10 | $303 |
| Novo Nordisk Inc | 4 | $213 |
| Ardelyx, Inc. | 3 | $209 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| PFIZER INC. | 2 | $52 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
| Celltrion USA Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: REZDIFFRA, TREMFYA, Wegovy, IBSRELA, SKYRIZI, LINZESS, XIFAXAN, VELSIPITY.
Industry payments across TN — which companies pay providers there.
